Portfolio Companies


DIABETES Care Group integrates state-of-the-art medical management, patient education and behavioral modification to improve patient self-management and clinical outcomes, while reducing the overall medical and social costs of diabetes.

DIAGNOVUS is a molecular diagnostics company targeting rare forms of cancer, including pediatric cancers. Diagnovus is dedicated to developing diagnostic tests that will better inform physicians, payers, patients and families facing these difficult disease prospects. The company will identify, in-license, develop and commercialize diagnostic assays that have been developed at leading institutions around the US.

MEDCENTERDISPLAY is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. The multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

Molecular Sensing (MSI) is an early-stage life sciences company dedicated to commercializing a new, game-changing molecular interaction biosensor technology, Back-Scattering Interferometry (BSI). BSI addresses unmet needs in pharmaceutical drug discovery and development, biomedical research, and diagnostics by overcoming the limitations of SPR and ITC, while combining their advantages in a single, synergistic platform.